Vimarsana
Biggest News Aggregation in the World

Page 38 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

Kaiser Aluminum (NASDAQ:KALU) Hits New 12-Month High at $102.42 - Vimarsana News

Kaiser Aluminum (NASDAQ:KALU) Hits New 12-Month High at $102.42

Kaiser Aluminum Co. (NASDAQ:KALU – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $102.42 and last traded at $101.60, with a volume of 23189 shares changing hands. The stock had previously closed at $100.98. Wall Street Analyst Weigh In Several analysts have recently […]

Redfin (NASDAQ:RDFN) Shares Down 3.5% - Vimarsana News

Redfin (NASDAQ:RDFN) Shares Down 3.5%

Redfin Co. (NASDAQ:RDFN – Get Free Report)’s share price dropped 3.5% during mid-day trading on Monday . The company traded as low as $7.24 and last traded at $7.27. Approximately 1,503,659 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 5,183,023 shares. The stock had previously closed at […]

Lifesci Capital Comments on Enliven Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ELVN) - Vimarsana News

Lifesci Capital Comments on Enliven Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ELVN)

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Lifesci Capital issued their Q2 2024 EPS estimates for Enliven Therapeutics in a report released on Wednesday, May 15th. Lifesci Capital analyst S. Slutsky anticipates that the company will post earnings per share of ($0.51) for the quarter. The consensus estimate for Enliven Therapeutics’ current full-year earnings […]

HC Wainwright Increases Cassava Sciences (NASDAQ:SAVA) Price Target to $131.00 - Vimarsana News

HC Wainwright Increases Cassava Sciences (NASDAQ:SAVA) Price Target to $131.00

Cassava Sciences (NASDAQ:SAVA – Get Free Report) had its price objective lifted by HC Wainwright from $124.00 to $131.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price suggests a potential upside of 466.61% from the company’s previous close. Cassava Sciences Stock […]

Freshworks Inc. (NASDAQ:FRSH) Receives $22.59 Consensus PT from Analysts - Vimarsana News

Freshworks Inc. (NASDAQ:FRSH) Receives $22.59 Consensus PT from Analysts

Shares of Freshworks Inc. (NASDAQ:FRSH – Get Free Report) have been given an average rating of “Moderate Buy” by the seventeen ratings firms that are covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price […]

Source: wkrb13.com